We conclude that GPR81 upregulation in the tumor microenvironment supports breast cancer aggressiveness at least in part via DLL4 upregulation and remodeling of ECM composition and cell–cell and cell–matrix interactions. The gene discussed is HCAR1; the disease is breast cancer.